Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Rheumatology

The Biology and Symptoms of Schnitzler Syndrome

At a Glance

Schnitzler syndrome is a rare whole-body inflammatory disorder, not an allergy. Ongoing IL-1β activity and a monoclonal IgM or IgG protein are linked to a non-itchy hives-like rash, recurring fevers, bone pain, and fatigue.

While Schnitzler syndrome may look like a skin condition at first glance, it is actually a complex “whole-body” inflammatory disorder. It is not an allergy, and it is not caused by anything you ate or touched [1]. Instead, it is a malfunction of your innate immune system—the part of your immune system that acts as your body’s first line of defense.

The Biology: An Internal Signal

The driving force behind Schnitzler syndrome is a protein called Interleukin-1 beta (IL-1β) [2]. In a healthy body, IL-1β is only released to fight off infections or heal injuries. In Schnitzler syndrome, it is thought to involve an internal “machine” in your cells called the inflammasome becoming overactive [3]. This causes the signal of IL-1β to stay on constantly, even when there is no infection to fight. This constant signal tells your body to create a fever, cause pain, and send inflammatory cells to your skin [1][4].

The second key biological feature is a monoclonal gammopathy [5]. This is a technical way of saying that a single group of immune cells (a clone of antibody-producing B cells or plasma-cell-related cells) in your bone marrow is producing an identical, “copy-paste” version of a protein (usually IgM, or less commonly IgG) [6][7]. While this protein is a hallmark of the disease, scientists are still researching exactly how it relates to the IL-1 inflammation.

Recognizing the Symptoms

The symptoms of Schnitzler syndrome are “systemic,” meaning they affect multiple parts of the body at once:

  • The Rash: This is often the first sign. It looks like pink or red hives (urticaria). Unlike typical allergies, this rash is usually non-pruritic (not itchy), though it may sting or feel slightly “prickly” [8][9]. Individual spots typically disappear within 24 hours without leaving bruises or scars [10].
  • Recurrent Fevers: Many patients experience fevers (often above 38°C or 100.4°F) that come and go, sometimes daily [11][12].
  • Bone and Joint Pain: This is a distinct feature. Patients often report deep, aching pain in their “long bones,” such as the shins (tibia) or thighs (femur) [13][14].
  • Fatigue and Swelling: You may feel profound exhaustion, and your doctor might find enlarged lymph nodes or an enlarged liver/spleen during an exam [12][15].

What It Is Not: Differential Diagnosis

Because Schnitzler syndrome is so rare, it is frequently mistaken for other conditions. Your care team will work to evaluate these look-alikes. Note that these tests require specialist interpretation, and a single negative finding does not automatically exclude a condition:

Condition Why it’s different from Schnitzler
Chronic Spontaneous Urticaria (CSU) CSU is a common allergy-like hive condition. It is usually very itchy, responds well to antihistamines, and does not cause fevers or bone pain [10][16].
Urticarial Vasculitis These “hives” are actually inflamed blood vessels. They often burn or hurt more than they itch, last longer than 24 hours in the same spot, and can leave a bruise-like mark when they fade [17][10].
Adult-Onset Still’s Disease (AOSD) AOSD causes high daily fevers and a salmon-colored rash, but it does not involve the specific monoclonal blood protein found in Schnitzler [18][19].
CAPS These are genetic conditions that often start in childhood, though they can present later. While they involve the same IL-1 pathway, they are typically caused by a specific gene mutation (NLRP3) and do not feature the monoclonal protein [20][21].
VEXAS Syndrome This condition causes similar inflammation and is identified by a specific mutation (UBA1). While often seen in older men and supported by “vacuoles” (tiny holes) in bone marrow cells, it can occur in other demographics [22][23].

By distinguishing your symptoms from these other conditions, your doctors can confirm that your inflammation is indeed driven by the specific Schnitzler pathway, allowing for targeted treatment.

Common questions in this guide

Is Schnitzler syndrome an allergy?
No. It is a rare whole-body inflammatory disorder involving an overactive innate immune signal, not a reaction to food or something touching the skin. The ongoing IL-1β signal can drive fever, pain, and skin inflammation.
What does the rash of Schnitzler syndrome look and feel like?
It usually appears as pink or red hives that are not very itchy; they may sting or feel prickly. Individual spots generally disappear within 24 hours without bruising or scarring.
What are the most common symptoms of Schnitzler syndrome?
Symptoms can include recurring fevers, deep aching pain in long bones such as the shins or thighs, fatigue, and a hives-like rash. Some people also have swollen lymph nodes or an enlarged liver or spleen.
Why is a monoclonal protein important in Schnitzler syndrome?
A monoclonal protein is an identical antibody protein made by one group of immune cells, usually IgM and less often IgG. Its presence is a key feature of Schnitzler syndrome, although researchers are still studying how it relates to IL-1 inflammation.
How is Schnitzler syndrome different from ordinary chronic hives?
Chronic spontaneous urticaria usually causes significant itching, often improves with antihistamines, and does not cause recurring fevers or deep bone pain. Schnitzler syndrome more often causes a non-itchy rash together with whole-body inflammation, fever, and bone pain.
What other conditions can look like Schnitzler syndrome?
Doctors may consider urticarial vasculitis, adult-onset Still’s disease, cryopyrin-associated periodic syndromes, and VEXAS syndrome. Skin findings, blood tests, genetic testing, and the pattern of symptoms can help separate them, but one negative result does not automatically rule out a condition.
What tests might help evaluate suspected Schnitzler syndrome?
A clinician may review the monoclonal IgM or IgG level, examine a skin biopsy, and monitor inflammation such as Serum Amyloid A. Depending on the symptoms, fever pattern, age, and blood counts, they may also review ferritin or consider testing for the UBA1 mutation linked to VEXAS syndrome.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Schnitzler syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my skin biopsy show 'neutrophilic urticarial dermatosis' without signs of vasculitis?
  2. 2.What was the exact level of my monoclonal protein (IgM or IgG), and how often should we check it?
  3. 3.How do my ferritin levels and fever patterns compare to what is typical for Adult-Onset Still’s Disease?
  4. 4.Based on my age and blood counts, should we consider testing for the UBA1 mutation associated with VEXAS syndrome?
  5. 5.Can we test my Serum Amyloid A (SAA) levels to better monitor my baseline inflammation?

References

References (23)
  1. 1

    Schnitzler Syndrome: the paradigm of an acquired adult-onset auto-inflammatory disease.

    Gusdorf L, Lipsker D

    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2020; (155(5)):567-573 doi:10.23736/S0392-0488.20.06692-4.

    PMID: 33295738
  2. 2

    Mast-cell interleukin-1β, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome.

    de Koning HD, van Vlijmen-Willems IM, Rodijk-Olthuis D, et al.

    The British journal of dermatology 2015; (173(2)):448-56 doi:10.1111/bjd.13857.

    PMID: 25904179
  3. 3

    FACS-based detection of extracellular ASC specks from NLRP3 inflammasomes in inflammatory diseases.

    Topping J, Lara-Reyna S, Ibbotson A, et al.

    Clinical and experimental immunology 2025; (219(1)) doi:10.1093/cei/uxae117.

    PMID: 39657685
  4. 4

    Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients.

    Kambe N, Inoue N, Ueki Y, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2025; (74(4)):605-615 doi:10.1016/j.alit.2025.04.003.

    PMID: 40393905
  5. 5

    Refractory serum immunoglobulin M elevation during anti-interleukin (IL)-1- or IL-6-targeted treatment in four patients with Schnitzler syndrome.

    Takimoto-Ito R, Kambe N, Kogame T, et al.

    The Journal of dermatology 2021; (48(11)):1789-1792 doi:10.1111/1346-8138.16124.

    PMID: 34435697
  6. 6

    Schnitzler Syndrome Without a Monoclonal Gammopathy: A Case Report.

    Urbanski M, Holfeld K, Milne A, Abbas M

    Journal of cutaneous medicine and surgery 2016; (20(6)):575-578 doi:10.1177/1203475416657999.

    PMID: 27358310
  7. 7

    A Rare but Fascinating Disorder: Case Collection of Patients with Schnitzler Syndrome.

    Bashir M, Bettendorf B, Hariman R

    Case reports in rheumatology 2018; (2018()):7041576 doi:10.1155/2018/7041576.

    PMID: 29707401
  8. 8

    Correlative bone imaging in a case of Schnitzler's syndrome and brief review of the literature.

    Willekens I, Walgraeve N, Goethals L, De Geeter F

    Hellenic journal of nuclear medicine 2015; (18(1)):71-3.

    PMID: 25840575
  9. 9

    Neutrophilic Urticarial Dermatosis.

    Orakwue A, Bray J, Comfere N, Sokumbi O

    Dermatologic clinics 2024; (42(2)):219-229 doi:10.1016/j.det.2023.08.009.

    PMID: 38423683
  10. 10

    The many faces of pediatric urticaria.

    Sekerel BE, Ilgun Gurel D, Sahiner UM, et al.

    Frontiers in allergy 2023; (4()):1267663 doi:10.3389/falgy.2023.1267663.

    PMID: 38026129
  11. 11

    [Schnitzler syndrome is a diagnostic challenge].

    Duhn PH, Thomsen SF, Nordin H

    Ugeskrift for laeger 2015; (177(30)).

    PMID: 26240044
  12. 12

    Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.

    Rowczenio DM, Pathak S, Arostegui JI, et al.

    Blood 2018; (131(9)):974-981 doi:10.1182/blood-2017-10-810366.

    PMID: 29284595
  13. 13

    Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients.

    Darrieutort-Laffite C, Ansquer C, Aubert H, et al.

    Arthritis research & therapy 2020; (22(1)):272 doi:10.1186/s13075-020-02318-5.

    PMID: 33208192
  14. 14

    Association of CCL2 with systemic inflammation in Schnitzler syndrome.

    Krause K, Sabat R, Witte-Händel E, et al.

    The British journal of dermatology 2019; (180(4)):859-868 doi:10.1111/bjd.17334.

    PMID: 30339714
  15. 15

    Clinical characterization and long-term follow-up of Schnitzler syndrome.

    Gameiro A, Gouveia M, Pereira M, et al.

    Clinical and experimental dermatology 2016; (41(5)):461-7 doi:10.1111/ced.12828.

    PMID: 27238847
  16. 16

    Hypocomplementemic Urticarial Vasculitis Syndrome or Systemic Lupus Erythematosus in Evolution?

    Kesarwani V, Phachu D, Trivedi R

    Cureus 2022; (14(3)):e23429 doi:10.7759/cureus.23429.

    PMID: 35481300
  17. 17

    Urticarial vasculitis and urticarial autoinflammatory syndromes.

    Marzano AV, Tavecchio S, Venturini M, et al.

    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2015; (150(1)):41-50.

    PMID: 25586657
  18. 18

    Refractory adult-onset Still's disease complicated with monoclonal gammopathy of undetermined significance: A case report.

    Saito K, Asano T, Matsumoto H, et al.

    Medicine 2022; (101(49)):e32107 doi:10.1097/MD.0000000000032107.

    PMID: 36626532
  19. 19

    A patient with urticarial lesions, recurrent fever, and IgM-type monoclonal gammopathy.

    Kecelj Žgank B, Benko M

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2022; (31(Suppl)):S27-S29.

    PMID: 35339140
  20. 20

    Chronic Urticaria-Associated Syndromes: Is Andersen-Tawil Syndrome One of Them?

    Bulat V, Zanze L, Peček M, et al.

    Genes 2026; (17(8)) doi:10.3390/genes17080976.

    PMID: 42650168
  21. 21

    Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.

    Matsuda T, Takimoto-Ito R, Lipsker D, Kambe N

    Allergology international : official journal of the Japanese Society of Allergology 2023; (72(3)):385-393 doi:10.1016/j.alit.2023.02.005.

    PMID: 36906447
  22. 22

    Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.

    Kouranloo K, Dey M, Almutawa J, et al.

    Rheumatology international 2024; (44(7)):1219-1232 doi:10.1007/s00296-023-05513-0.

    PMID: 38129348
  23. 23

    Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

    Caggiano V, Sbalchiero J, Frassi M, et al.

    Frontiers in medicine 2025; (12()):1659758 doi:10.3389/fmed.2025.1659758.

    PMID: 41601749

This page explains the biology, symptoms, and possible look-alike conditions of Schnitzler syndrome for informational purposes only and does not constitute medical advice. A qualified clinician should interpret your tests and guide your diagnosis and care.